Norbrook OstiLox (meloxicam oral suspension) (3 products)
Recall announced April 29, 2020 by NORBROOK INC, posted by the U.S. Food and Drug Administration (FDA). Reason: Product is considered to be manufactured outside the conditions of the application. It affects dogs. The agency has closed this recall.
- Where sold
- IA, KS, MO, OH
- Last updated
- November 20, 2026
Products included
- OstiLox (meloxicam oral suspension), 1.5 mg/mL, 100 mL per vial, Manufactured for: MWI, Boise, ID 83705, Manufactured by: Norbrook Laboratories Limited, Newry, Co. Down, BT35 6PU, Northern Ireland. NDC: 13985-613-01 (Batches 0045-90A, 0054-92C)
- Meloxicam oral suspension, 1.5 mg/mL, 100 mL per vial, Distributed by: Covetrus North America, 400 Metro Place North, Dublin, OH 43017. NDC: 11695-6937-3 (Batches 0045-90A, 0054-92C)
- Loxicom (meloxicam oral suspension), 1.5 mg/mL, 100 mL per vial, Manufactured by: Norbrook Laboratories Limited, Newry, Co. Down, BT35 6PU, Northern Ireland. NDC: 55529-041-02 (Batches 0045-90A, 0054-92C)
Read the official notice. Always compare the codes on your package with the official notice. It is the final word.
Has your pet used this product and seems unwell? Call your veterinarian or an emergency animal hospital now.
